Sanofi signs $925 million inhaled insulin deal
August 13, 2014Sales and Marketing Afrezza, French, Sanofi, diabetes, fad, insulin
Sanofi could pay out as much as $925 million for global rights to the world’s only approved inhaled insulin just …
Cancer Research UK appeals for clarity on Wikipedia
August 13, 2014Medical Communications, Sales and Marketing Cancer, Cancer Research UK, wikimania, wikipedia
Cancer Research UK is calling upon the medical community to become more involved with Wikipedia to ensure better accuracy of …
Untested Ebola drugs can be used in Africa
August 13, 2014Research and Development, Sales and Marketing Africa, Biocryst Pharmaceuticals, Ebola, Siga Technologies, Tekmira Pharmaceuticals, WHO, world health organization, zmapp
The World Health Organization will allow untested treatments for Ebola to be used in West Africa as the death toll …
Cost of diabetes treatment soars in England
August 13, 2014Medical Communications, Research and Development, Sales and Marketing Lantus, NHS, Sanofi, diabetes
The NHS spent more than £2.2 million on average every day over the last financial year on diabetes medicines, according …
GSK now faces bribery allegations in Syria
August 13, 2014Medical Communications, Sales and Marketing China, GSK, bribery
GlaxoSmithKline faces fresh allegations that it bribed Syrian doctors and officials to boost sales of its medicines in what is …
Spectrum appoints two medical writers
August 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dominique Helburg, Nuša Farič, Spectrum
UK Healthcare consultancy firm Spectrum Regulatory Solutions has appointed two new medical writers to further expand its team. Prior to …
Nicox makes changes to board
August 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adrienne Graves, Luzi von Bidder, NicOx
French ophthalmic firm Nicox has confirmed that Dr Adrienne Graves and Luzi von Bidder will be joining its board of …
GSK Ebola vaccine underway
August 11, 2014Research and Development, Sales and Marketing Africa, Ebola, GSK, Vaccine, WHO, johnson
Clinical trials of an experimental vaccine against the deadly Ebola virus will begin soon according to its developers GlaxoSmithKline. The …
Synta appoints Sanofi president as chief executive
August 11, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Synta, anne whitaker
US biopharma firm Synta Pharmaceuticals has confirmed that Anne Whitaker is joining the company as president and chief executive. Whitaker …
GSK investigator jailed by Chinese police
August 8, 2014Medical Communications, Research and Development, Sales and Marketing China, GSK, Peter Humprhey
A private investigator hired by GlaxoSmithKline to look into the secret recording of a sex tape of its China boss …
Digital: bridging the gap between doctor, pharma and patient
August 8, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing digital, doctors, pm society, social media
Digital technology is moving on apace, but is the pharma industry keeping up and just what are the opportunities to …
Cancer Research UK and Astellas announce partnership
August 8, 2014Medical Communications, Research and Development, Sales and Marketing Astellas, CRUK, Canncer, Pancreatic cancer
Cancer Research UK and its commercial arm, Cancer Research Technology (CRT) have announced they are joining forces with Astellas in …
Quanta appoints new chief financial officer
August 8, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Quanta Fluid Solutions, a developer of advanced haemodialysis systems has appointed Willem Baralt as its new chief financial officer. Baralt …
RBS chairman favoured as next GSK head
August 8, 2014Medical Communications, Research and Development, Sales and Marketing China, GSK, RBS, Sir Christopher Gent
The Royal Bank of Scotland’s current head Sir Philip Hampton is the most likely candidate to take over as the …
Storm brewing over Roche cancer drug price
August 8, 2014Medical Communications, Research and Development, Sales and Marketing Cancer, Haslam, Kadcyla, NICE, Roche, Yervoy, rejection
The Breakthrough Breast Cancer charity and England’s drug pricing watchdog NICE have both attacked Roche for not lowering the price …
Hanover appoints former MHP executive
August 7, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanover, mhp
Med comms firm Hanover has appointed Richard Sloggett as its new associate director, poaching him from its rival MHP Health. …
Astellas Pharma announces new senior hires
August 7, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas
Astellas Pharma EMEA, the European division of Astellas Pharma, has appointed Simon Dew to the position of chief strategy officer …
Cerner acquires Siemens Health Services for $1.3bn
August 7, 2014Medical Communications, Sales and Marketing Health IT, Siemens, imaging, mhealth
Cerner Corporation has signed a deal sealing its takeover of Siemens Health Services for $1.3 billion in cash. Cerner will …
AbbVie/Shire deal under threat from tax laws
August 7, 2014Medical Communications, Sales and Marketing AbbVie, AstraZeneca, Pfizer, Shire, tax inversion
The £32 billion deal between AbbVie and Irish specialist biotech Shire could be under threat from new rules in the …
New app allows blood imaging from a smartphone
August 7, 2014Medical Communications, Research and Development app, digital, smartphone
An IT research team has developed a new smartphone app that works in conjunction with a small lens add-on that …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
